Transcriptional regulation and chromatin structure of the human CD34 gene promoter region.

Abstract:

:The human CD34 surface antigen is selectively expressed on stem/progenitor cells within the hematopoietic system. Because CD34 expression is tightly linked to the immature status of hematopoietic cells, with expression being rapidly lost as hematopoietic cells mature and differentiate, an examination of its regulation may provide important insights into the molecular control of blood cell development. A comparison of the CD34 nuclear transcription rate in CD34+ and CD34- cells indicated that the CD34 gene is transcriptionally regulated in hematopoietic cell lines. In a previous report, we had identified two major clusters of CD34 transcription initiation sites by 5' RACE (rapid amplification of cDNA ends) analysis. In transient transfection experiments, we now demonstrate the ability of sequences encompassing each of these clusters to function as promoters of transcription in CD34+ cells. These promoters functioned at equivalent levels in CD34+ and CD34- cells, and the addition of 5' flanking sequences, extending as far as 3.7 kb upstream, to the core promoters did not differentially modify the level of expression in CD34+ versus the CD34- cell lines. An examination of DNase I hypersensitivity sites within an 18-kb segment of DNA, extending 9 kb either side of the proximal promoter, showed six sites that were primarily associated with CD34- expressing cells. Taken together, these data indicate that the CD34 promoter sequences alone do not confer tissue-or stage-specific expression. Appropriate transcriptional regulation of the CD34 gene must be controlled by chromatin structure, as identified by DNase I hypersensitivity, and/or by other tissue- and stage-specific elements present outside of the promoter region.

journal_name

Blood

journal_title

Blood

authors

He XY,Cockerill PN,Cen D,Davis BR

subject

Has Abstract

pub_date

1994-04-01 00:00:00

pages

1822-30

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

83

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.

    abstract::Using urea-solubilized human fibrin monomer as an immunogen, we raised in mice a battery of monoclonal antibodies that reacted with the immunogen but not with urea-treated or native fibrinogen. Although they all failed to react with acid-solubilized fibrin monomer (acid-FM) alone, an antibody designated as IF-43 was f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Soe G,Kohno I,Inuzuka K,Itoh Y,Matsuda M

    更新日期:1996-09-15 00:00:00

  • Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses.

    abstract::Factor V Leiden (FVL) is associated with venous thrombosis; however, an association between FVL and arterial thrombosis remains controversial. We investigated FVL as a risk factor for myocardial infarction (MI), ischemic stroke (IS), or non-MI ischemic heart disease (non-MI-IHD). The design was 3 case-control studies ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2002-01-0111

    authors: Juul K,Tybjaerg-Hansen A,Steffensen R,Kofoed S,Jensen G,Nordestgaard BG

    更新日期:2002-07-01 00:00:00

  • Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.

    abstract::To evaluate internal tandem duplication (ITD) insertion sites and length as well as their clinical impact in younger adult patients with FLT3-ITD-positive acute myeloid leukemia (AML), sequencing after DNA-based amplification was performed in diagnostic samples from 241 FLT3-ITD-mutated patients. All patients were tre...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2009-03-209999

    authors: Kayser S,Schlenk RF,Londono MC,Breitenbuecher F,Wittke K,Du J,Groner S,Späth D,Krauter J,Ganser A,Döhner H,Fischer T,Döhner K,German-Austrian AML Study Group (AMLSG).

    更新日期:2009-09-17 00:00:00

  • Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector.

    abstract::Gene therapy for hemophilia A requires efficient delivery of the factor VIII gene and sustained protein expression at circulating levels of at least 1% to 2% of normal. Adeno-associated viral type 2 (AAV2) vectors have a number of advantages over other viral vectors, including an excellent safety profile and persisten...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0292

    authors: Scallan CD,Lillicrap D,Jiang H,Qian X,Patarroyo-White SL,Parker AE,Liu T,Vargas J,Nagy D,Powell SK,Wright JF,Turner PV,Tinlin SJ,Webster SE,McClelland A,Couto LB

    更新日期:2003-09-15 00:00:00

  • Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.

    abstract::ASXL1 is mutated/deleted with high frequencies in multiple forms of myeloid malignancies, and its alterations are associated with poor prognosis. De novo ASXL1 mutations cause Bohring-Opitz syndrome characterized by multiple congenital malformations. We show that Asxl1 deletion in mice led to developmental abnormaliti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-500272

    authors: Wang J,Li Z,He Y,Pan F,Chen S,Rhodes S,Nguyen L,Yuan J,Jiang L,Yang X,Weeks O,Liu Z,Zhou J,Ni H,Cai CL,Xu M,Yang FC

    更新日期:2014-01-23 00:00:00

  • Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.

    abstract::Protein disulfide isomerase (PDI) derived from intravascular cells is required for thrombus formation. However, it remains unclear whether platelet PDI contributes to the process. Using platelet-specific PDI-deficient mice, we demonstrate that PDI-null platelets have defects in aggregation and adenosine triphosphate s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-492504

    authors: Kim K,Hahm E,Li J,Holbrook LM,Sasikumar P,Stanley RG,Ushio-Fukai M,Gibbins JM,Cho J

    更新日期:2013-08-08 00:00:00

  • Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.

    abstract::Circulating monoclonal B cells may be detected in healthy adults, a condition called monoclonal B-cell lymphocytosis (MBL). MBL has also been identified in donated blood, but no systematic study of blood donors has been reported. Using sensitive and specific laboratory methods, we detected MBL in 149 (7.1%; 95% confid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-08-523704

    authors: Shim YK,Rachel JM,Ghia P,Boren J,Abbasi F,Dagklis A,Venable G,Kang J,Degheidy H,Plapp FV,Vogt RF,Menitove JE,Marti GE

    更新日期:2014-02-27 00:00:00

  • A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene.

    abstract::Hypoxia is a strong stimulus for the transcription of a set of genes, including erythropoietin and vascular endothelial growth factor. Here we report on the cloning, functional significance, and expression of a complementary DNA (cDNA) that is involved in hypoxia-mediated expression of these 2 genes. The full-length c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gupta M,Mungai PT,Goldwasser E

    更新日期:2000-07-15 00:00:00

  • Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.

    abstract::Hematopoietic growth factors (HGFs) interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) individually have been shown to increase the percentage of acute myeloid leukemia (AML) blasts in S phase and enhance the cytotoxic effects of Ara-C against these blasts in culture. We compared in vit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bhalla K,Holladay C,Arlin Z,Grant S,Ibrado AM,Jasiok M

    更新日期:1991-11-15 00:00:00

  • Immunogenic nature of a Pol gene product of HTLV-III/LAV.

    abstract::The present studies were initiated to define the coding region of a 34 kilodalton (kd) protein (p34) frequently observed with antibodies from HTLV-III/LAV-infected people by immunoblotting and radioimmunoprecipitation (RIP) techniques. We have directly mapped this viral protein to the pol gene of HTLV-III/LAV by radio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Allan JS,Coligan JE,Lee TH,Barin F,Kanki PJ,M'Boup S,McLane MF,Groopman JE,Essex M

    更新日期:1987-01-01 00:00:00

  • TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice.

    abstract::Immunoglobulin class switching from IgM to IgG in response to peptides is generally T cell-dependent and vaccination in T cell-deficient individuals is inefficient. We show that a vaccine consisting of a dense array of peptides on liposomes induced peptide-specific IgG responses totally independent of T-cell help. Ind...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-02-413831

    authors: Pihlgren M,Silva AB,Madani R,Giriens V,Waeckerle-Men Y,Fettelschoss A,Hickman DT,López-Deber MP,Ndao DM,Vukicevic M,Buccarello AL,Gafner V,Chuard N,Reis P,Piorkowska K,Pfeifer A,Kündig TM,Muhs A,Johansen P

    更新日期:2013-01-03 00:00:00

  • A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes.

    abstract::The regulator of G-protein signaling (RGS) negatively regulates the alpha subunit of G proteins by accelerating their intrinsic guanosine triphosphatase (GTPase) activity. Here are reported the isolation and characterization of a novel mouse RGS, termed RGS18, which is a new member of RGS subfamily B. Northern blot an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.3051

    authors: Nagata Y,Oda M,Nakata H,Shozaki Y,Kozasa T,Todokoro K

    更新日期:2001-05-15 00:00:00

  • EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.

    abstract::Fetal hemoglobin (HbF, α2γ2) induction is a well-validated strategy for sickle cell disease (SCD) treatment. Using a small-molecule screen, we found that UNC0638, a selective inhibitor of EHMT1 and EHMT2 histone methyltransferases, induces γ-globin expression. EHMT1/2 catalyze mono- and dimethylation of lysine 9 on hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-06-649087

    authors: Renneville A,Van Galen P,Canver MC,McConkey M,Krill-Burger JM,Dorfman DM,Holson EB,Bernstein BE,Orkin SH,Bauer DE,Ebert BL

    更新日期:2015-10-15 00:00:00

  • The treatment of Burkitt lymphoma in adults.

    abstract::Burkitt lymphoma (BL) is a highly aggressive, B-cell, non-Hodgkin lymphoma (NHL) categorized into endemic, sporadic and immunodeficiency-associated subtypes. BL has distinct pathologic and clinical features, characterized by rapidly progressive tumors with high rates of extranodal involvement. Next generation sequenci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004099

    authors: Crombie JL,LaCasce AS

    更新日期:2020-11-10 00:00:00

  • The amino-terminal 29- and 72-Kd fragments of fibronectin mediate selective monocyte recruitment.

    abstract::Proteolytic fragments of fibronectin (Fn) can possess properties not inherent to intact Fn. Previously, only mixtures of low molecular weight Fn fragments, and the 120-Kd fibroblastic cell-binding segment, but not intact Fn, were shown to be selectively chemotactic for human monocytes (MOs). In order to determine if o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lohr KM,Kurth CA,Xie DL,Seyer JM,Homandberg GA

    更新日期:1990-11-15 00:00:00

  • A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.

    abstract::Interest in high-dose cytarabine (HDAC) for both induction and postremission therapy for acute myeloid leukemia (AML) prompted the Southwest Oncology Group (SWOG) to initiate a randomized trial comparing HDAC with standard-dose cytarabine (SDAC) for remission induction of previously untreated AML and to compare high-d...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Weick JK,Kopecky KJ,Appelbaum FR,Head DR,Kingsbury LL,Balcerzak SP,Bickers JN,Hynes HE,Welborn JL,Simon SR,Grever M

    更新日期:1996-10-15 00:00:00

  • Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages.

    abstract::Pluripotent hematopoietic stem cells have been studied extensively, but the events that occur during their differentiation remain largely uncharted. To develop a system that allows the differentiation of cultured multipotent progenitors by time-lapse fluorescence microscopy, myelomonocytic cells were labeled with gree...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Faust N,Varas F,Kelly LM,Heck S,Graf T

    更新日期:2000-07-15 00:00:00

  • Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

    abstract::Using data from ARISTOTLE, we describe the periprocedural management of anticoagulation and rates of subsequent clinical outcomes among patients chronically anticoagulated with warfarin or apixaban. We recorded whether (and for how long) anticoagulant therapy was interrupted preprocedure, whether bridging therapy was ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-08-595496

    authors: Garcia D,Alexander JH,Wallentin L,Wojdyla DM,Thomas L,Hanna M,Al-Khatib SM,Dorian P,Ansell J,Commerford P,Flaker G,Lanas F,Vinereanu D,Xavier D,Hylek EM,Held C,Verheugt FW,Granger CB,Lopes RD

    更新日期:2014-12-11 00:00:00

  • Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

    abstract::During an 8-year period, 3,638 children from institutions of the Pediatric Oncology Group (POG) were diagnosed with acute lymphoblastic leukemia (ALL). Fifty-seven patients had Philadelphia chromosome-positive (Ph1) ALL. Blast cells obtained at diagnosis from 13 of these 57 cases (23%) were also found to have partial ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Russo C,Carroll A,Kohler S,Borowitz M,Amylon M,Homans A,Kedar A,Shuster J,Land V,Crist W

    更新日期:1991-03-01 00:00:00

  • Iron incorporation into ferritin and hemoglobin during differentiation of murine erythroleukemia cells.

    abstract::Hemoglobin and ferritin iron content have been followed during differentiation in tissue cultures of murine erythroleukemia cells (MELC) using the techniques of Mössbauer spectroscopy and electron microscopy. In undifferentiated cells grown without DMSO, only iron stored in ferritin was detected. The amount of iron in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ofer S,Fibach E,Kessel M,Bauminger ER,Cohen SG,Eikelboom J,Rachmilewitz EA

    更新日期:1981-08-01 00:00:00

  • Synthesis of a peroxidase activity by the cells of hairy cell leukemia: a study by ultrastructural cytochemistry.

    abstract::The nature of cells present in the blood, marrow, and spleen of patients with hairy cell leukemia is largely debated. These cells have been tentatively categorized on the basis of either monocytic or lymphocytic markers, and the accumulating data points to the fact that they share some characteristics of both cell typ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reyes F,Gourdin MF,Farcet JP,Dreyfus B,Breton-Gorius J

    更新日期:1978-09-01 00:00:00

  • p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).

    abstract::The t(11;14)(q13;q32) translocation, which juxtaposes the BCL1 oncogene with the Ig heavy chain locus, has been associated with an uncommon subtype of non-Hodgkin's lymphoma (NHL) termed mantle cell lymphoma (MCL). To date, no molecular marker that serves as an indicator of tumor progression or clinical prognosis has ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Louie DC,Offit K,Jaslow R,Parsa NZ,Murty VV,Schluger A,Chaganti RS

    更新日期:1995-10-15 00:00:00

  • Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

    abstract::We treated 109 patients with adult acute lymphoblastic leukemia (ALL) diagnosed by histochemical and immunologic techniques. Patients were excluded only for age greater than 50 years and Burkitt's leukemia. Treatment included a four-drug remission induction phase followed by alternating cycles of noncrossresistant che...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Linker CA,Levitt LJ,O'Donnell M,Forman SJ,Ries CA

    更新日期:1991-12-01 00:00:00

  • Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agents.

    abstract::3-Hydroxypropyl flufenamide (Flu-HPA) is one of a series of flufenamic acid derivatives that enhances blood clot lysis in vitro. Studies of possible mechanisms of action of Flu-HPA were undertaken. The profibrinolytic activity of Flu-HPA in clot lysis assays was found to be dependent on plasminogen. The influence of F...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miles LA,Burnier JP,Verlander MS,Goodman M,Kleiss AJ,Griffin JH

    更新日期:1981-06-01 00:00:00

  • Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group.

    abstract::Transfusions purportedly induce dysfunction of cell-mediated immunity in sickle cell anemia (SCA). We studied hematologic and lymphocytic indices in 173 human immunodeficiency virus (HIV)-negative subjects with SCA and 131 black controls. Children aged 1 to 7 years with SCA had leukocyte counts and percentages of gran...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Wong WY,Powars DR,Operskalski EA,Hassett J,Parker JW,Sarnaik S,Pegelow CH,Hilgartner MW,Johnson CS,Zhou Y

    更新日期:1995-04-15 00:00:00

  • Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers.

    abstract::Although hepatitis C virus (HCV) mainly affects hepatocytes, infection is widespread and involves immunologically privileged sites. Whether lymphoid cells represent further targets of early HCV infection, or whether other cells in the hematopoietic microenvironment may serve as a potential virus reservoir, is still un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sansonno D,Lotesoriere C,Cornacchiulo V,Fanelli M,Gatti P,Iodice G,Racanelli V,Dammacco F

    更新日期:1998-11-01 00:00:00

  • How I treat venous thromboembolism in patients with cancer.

    abstract::Venous thromboembolism (VTE) is a frequent complication in cancer patients and represents an important cause of morbidity and mortality. Especially in patients who have a poor life expectancy, preventing death from pulmonary embolism is the mainstay of treatment. Critically ill patients should promptly be administered...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1508

    authors: Prandoni P

    更新日期:2005-12-15 00:00:00

  • Evidence that the Pim1 kinase gene is a direct target of HOXA9.

    abstract::The HOXA9 homeoprotein exerts dramatic effects in hematopoiesis. Enforced expression of HOXA9 enhances proliferation of primitive blood cells, expands hematopoietic stem cells (HSCs), and leads to myeloid leukemia. Conversely, loss of HOXA9 inhibits proliferation and impairs HSC function. The pathways by which HOXA9 a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-043356

    authors: Hu YL,Passegué E,Fong S,Largman C,Lawrence HJ

    更新日期:2007-06-01 00:00:00

  • A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement.

    abstract::The clinical hallmark of paroxysmal nocturnal hemoglobinuria (PNH) is chronic intravascular hemolysis that is a consequence of unregulated activation of the alternative pathway of complement (APC). Intravascular hemolysis can be inhibited in patients by treatment with eculizumab, a monoclonal antibody that binds compl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-09-244285

    authors: Lindorfer MA,Pawluczkowycz AW,Peek EM,Hickman K,Taylor RP,Parker CJ

    更新日期:2010-03-18 00:00:00

  • Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.

    abstract::Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare primary immunodeficiency caused by gain-of-function mutations in the CXCR4 gene. We report the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of mavorixafor from a phase 2 open-label dose-escalatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007197

    authors: Dale DC,Firkin F,Bolyard AA,Kelley M,Makaryan V,Gorelick KJ,Ebrahim T,Garg V,Tang W,Jiang H,Skerlj R,Beaussant Cohen S

    更新日期:2020-12-24 00:00:00